In a statement yesterday, ACS said its board had approved $1bn in shares, including the immediate purchase of $200m of common stock. The board expects to authorize further purchases under the $1bn program, ACS said.
The news didn’t do much to propel ACS shares, which were down 1% to close $40.84 on the New York Stock Exchange Monday.
